Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
NGNE
#2511
Neurogene, Inc. Common Stock
23.490
0
+21.87%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+21.87%
Aylık değişim
+18.04%
6 aylık değişim
-20.16%
Yıllık değişim
-20.16%
Önceki kapanış
19.275
0
Open
23.490
0
Bid
Ask
Low
23.490
0
High
23.490
0
Hacim
39
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NGNE
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
8.47 M
8.5 M
8.56 M
12.85 M
14.93 M
—
Valuation ratios
Enterprise value
—
—
—
107.18 M
204.7 M
652.93 M
Price to earnings ratio
—
—
—
-0.14
-5.34
-15.71
Price to sales ratio
—
—
—
—
434.14
—
Price to cash flow ratio
—
—
—
0.15
5.69
17.16
Price to book ratio
—
—
—
0.04
1.29
2.12
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.37
0.5
0.16
0.22
0.28
Return on equity %
0.17
0.42
0.61
0.2
0.24
0.3
Return on invested capital %
2 641.78
1 426.14
1 258.74
2 485.3
1 635.68
—
Gross margin %
100
100
100
—
100
—
Operating margin %
421.02
6.07 M
3 476.29
—
8 930.27
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
415.39
6.07 M
3 385.71
—
8 123.68
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.66
16.67
8.96
8.72
20.84
78.33
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0
0.01
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
4.32
4.13
130.28
4.02
3.83
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
12.94
8.73
499.72
17.78
57.3
Net current asset value per share
—
13.08
8.98
507.81
17.98
58.13
Tangible book value per share
—
12.97
8.54
471.5
17.67
57.09
Working capital per share
—
12.3
7.97
449.58
17.12
55.17
Book value per share
—
12.98
8.54
471.5
17.67
57.09
Haberler
Netflix, Dell among market cap stock movers on Friday
Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)
Neurogene hissesi FDA’nın çığır açan tedavi statüsüyle %30 yükseldi
Neurogene stock surges 30% on FDA breakthrough therapy status
FDA grants breakthrough therapy status to Neurogene’s Rett drug
Stifel, Neurogene hissesi için Al tavsiyesini yineliyor, güvenli marjı vurguluyor
Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin
Neurogene doses multiple patients in Rett syndrome gene therapy trial
Citizens, Taysha Gene Therapies hissesi için Piyasa Performansı Üstü notunu yineledi
Citizens reiterates Market Outperform rating on Taysha Gene Therapies stock
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE)